StockNews.com assumed coverage on shares of NantHealth (NASDAQ:NH – Get Rating) in a report issued on Tuesday morning. The brokerage issued a hold rating on the stock.
NantHealth Stock Performance
NASDAQ:NH opened at $2.26 on Tuesday. NantHealth has a one year low of $1.57 and a one year high of $11.98. The stock has a market cap of $17.42 million, a PE ratio of -0.30 and a beta of 1.86. The stock has a 50 day moving average price of $2.98 and a 200 day moving average price of $1.72.
Get
NantHealth alerts:
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently modified their holdings of NH. Atria Wealth Solutions Inc. boosted its position in shares of NantHealth by 117.7% during the second quarter. Atria Wealth Solutions Inc. now owns 491,942 shares of the company's stock worth $205,000 after buying an additional 265,949 shares during the period. Millennium Management LLC purchased a new position in shares of NantHealth during the second quarter worth $110,000. Finally, Goldman Sachs Group Inc. purchased a new position in shares of NantHealth during the second quarter worth $36,000. 4.50% of the stock is currently owned by hedge funds and other institutional investors.
NantHealth Company Profile
(Get Rating)
NantHealth, Inc is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer. The firm empowers treatment decisions, improves patient outcomes, validates treatment options, enables high-quality care, lowers costs, ensures appropriate reimbursement, and streamlines implementation and deployment.
Featured Stories
- Get a free copy of the StockNews.com research report on NantHealth (NH)
- Dividend King Genuine Parts Company Upgraded On Profit Guidance
- The Bottom Is In For Accenture
- 11 Best Consumer Discretionary Stocks of 2023
- 5 Best Dividend Capture Stocks
- 10 Best Consumer Discretionary ETFs
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.
StockNews.com承担了对以下股票的报道NantHealth(纳斯达克:NH-GET评级)在周二上午发布的一份报告中。该券商对该股发布了持有评级。
NantHealth股票表现
纳斯达克:NH周二开盘报2.26美元。NantHealth的一年低点为1.57美元,一年高位为11.98美元。该股市值为1,742万美元,市盈率为-0.30,贝塔系数为1.86。该股的50日移动均价为2.98美元,200日移动均价为1.72美元。
到达
NantHealth警报:
机构资金流入和流出
几家对冲基金和其他机构投资者最近调整了对NH的持股。Atria Wealth Solutions Inc.在第二季度将其在NantHealth的股票头寸增加了117.7%。Atria Wealth Solutions Inc.在此期间又购买了265,949股Atria Wealth Solutions Inc.,目前持有491,942股该公司股票,价值20.5万美元。Millennium Management LLC在第二季度购买了价值11万美元的NantHealth新股头寸。最后,高盛股份有限公司在第二季度购买了价值36,000美元的南洋健康新股头寸。4.50%的股票目前由对冲基金和其他机构投资者持有。
NantHealth公司简介
(获取评级)
NantHealth,Inc.是一家以证据为基础的个性化保健公司,致力于为癌症等危重疾病提供治疗。该公司支持治疗决策,改善患者结局,验证治疗选项,实现高质量护理,降低成本,确保适当的报销,并简化实施和部署。
专题报道
- 免费获取StockNews.com关于NantHealth(NH)的研究报告
- 红利王正品配件公司利润指引升级
- 埃森哲的底部已经到了
- 2023年11只最佳非必需消费品股票
- 5只最佳股利捕捉股
- 十大最佳消费者可自由支配ETF
接受《NantHealth Daily》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对NantHealth和相关公司的最新新闻和分析师评级的每日简要摘要。